In this study, PEGylated recombinant human arginase 1 (BCT-100) was shown to sharply deplete the levels of intracellular and intratumoral arginine and display an antiproliferative effect on tumor growth in bladder cancer cells. Here, PCYT1B is linked to urinary bladder cancer.